Microtubule Inhibitors Elicit Differential Effects on MAP Kinase (JNK, ERK, and p38) Signaling Pathways in Human KB-3 Carcinoma Cells
- 1 January 2000
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 254 (1), 110-119
- https://doi.org/10.1006/excr.1999.4731
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Stress-activated Protein Kinase/Jun N-terminal Kinase Is Required for Interleukin (IL)-1-induced IL-6 and IL-8 Gene Expression in the Human Epidermal Carcinoma Cell Line KBJournal of Biological Chemistry, 1998
- Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to developmentCurrent Opinion in Cell Biology, 1998
- Signal Transduction through MAP Kinase CascadesPublished by Elsevier ,1998
- The Jun Kinase/Stress-activated Protein Kinase Pathway Functions to Regulate DNA Repair and Inhibition of the Pathway Sensitizes Tumor Cells to CisplatinJournal of Biological Chemistry, 1997
- Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3Nature, 1997
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- Sounding the Alarm: Protein Kinase Cascades Activated by Stress and InflammationJournal of Biological Chemistry, 1996
- Signal Transduction Pathways Regulated by Mitogen-activated/Extracellular Response Kinase Kinase Kinase Induce Cell DeathJournal of Biological Chemistry, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- How MAP Kinases Are RegulatedJournal of Biological Chemistry, 1995